Salarius Pharmaceuticals, Inc. (SLRX) Reports Q2 Loss of $1.43
Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) reported Q2 EPS of ($1.43).
For earnings history and earnings-related data on Salarius Pharmaceuticals, Inc. (SLRX) click here.
Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) reported Q2 EPS of ($1.43).
For earnings history and earnings-related data on Salarius Pharmaceuticals, Inc. (SLRX) click here.